(Q51692708)

9 April 2018

title

A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain. (English)

1 reference

9 April 2018

0 references

0 references

E Bruera

1

1 reference

9 April 2018

C Ripamonti

2

1 reference

9 April 2018

C Brenneis

3

1 reference

9 April 2018

K Macmillan

4

1 reference

9 April 2018

J Hanson

5

1 reference

9 April 2018

publication date

1 April 1992

1 reference

9 April 2018

Journal of Pain and Symptom Management

published in

1 reference

9 April 2018

volume

7

1 reference

9 April 2018

page(s)

138-140

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

The treatment of cancer pain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

The Edmonton staging system for cancer pain: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

Dercum's disease (adiposis dolorosa). Treatment of the severe pain with intravenous lidocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

Lidocaine as an analgesic for experimental pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

Trial of intravenous lidocaine on painful neuropathy in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

Lidocaine treatment of painful diabetic neuropathy and endogenous opioid peptides in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2806%2980004-7

7 January 2021

10.1016/S0885-3924(06)80004-7

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

16967580

1 reference

9 April 2018